Faced with shortages, Switzerland plans to boost drug stocks
Faced with the current shortage of medicines, Bern wants to extend mandatory reserves of drugs and the obligation to declare stocks, says a top government official.
This content was published on
2 minutes
Keystone-SDA/jc
Italiano
it
Di fronte alla carenza di farmaci, la Svizzera prevede di incrementare le scorte di medicinali
Anti-epileptic drugs and medicines for Parkinson’s disease should be included in the mandatory reserves, Christoph Amstutz of the Federal Office for National Economic SupplyExternal link (FONES) told SRF radio on Friday. Medicines for mental disorders should also be included, said Amstutz, who heads the Therapeutic Products Division at FONES. If these drugs were to run out, it could have a very harmful effect on patients, he added.
For the first time, the authorities have classified the supply of certain drugs as “problematic”, Amstutz told SRF. In the past it has always been possible to resort to compulsory stockpiling or exchange of certain drugs in case of supply problems. Now, however, not all oral antibiotics are available, but that does not mean that people will die because of it.
Current shortages mostly concern medicines for children, according to Amstutz. This is mainly a seasonal phenomenon, due to the flu epidemic and infections in toddlers, but is also a side effect of the pandemic. He said more antibiotics have been used than in previous years.
The next stage would be if the situation were deemed “critical”, with individual products or whole groups of therapeutic agents no longer available. “I hope this will not happen in the future,” Amstutz said.
FONES is also working with the Federal Office of Public Health (FOPH) to develop a plan for security of medicine procurement. The intention is to make virtually all drugs reimbursed by health insurance funds subject to compulsory registration.
Most Read Swiss Abroad
More
Heard the one about the Swiss company installing laugh detectors?
Is artificial intelligence an advantage or a disadvantage for workers?
What is your experience with AI at work? Have you already used it? Has it helped you work better? Or has it caused you more stress, more work or caused you to lose your job? Tell us about your experiences!
Swiss price watchdog slams excessive prices for generic medicines
This content was published on
The cheapest generic medicines available in Switzerland are more than twice as expensive as in other countries, according to a study by the Swiss price watchdog.
Nature should not figure in net zero calculations: academic study
This content was published on
The natural removal of CO2 from the atmosphere by forests or oceans should not be included in the net-zero balance of climate protection measures, argue researchers.
This content was published on
None of the 15 major Swiss retail banks is meeting international climate and biodiversity targets, according to a ranking by WWF Switzerland.
This content was published on
Nestlé's new CEO Laurent Freixe, has presented plans for the future of the world's largest food company, after his first few weeks in office.
Swiss foreign minister calls on Moscow to end Ukraine war
This content was published on
It's high time Moscow ended its war against Ukraine, Swiss foreign minister Ignazio Cassis tells the UN Security Council.
This content was published on
The only alternative to the UN Palestinian agency’s work in Gaza is to allow Israel to run services there, Philippe Lazzarini, UNRWA Commissioner-General, told reporters in Geneva on Monday.
Study reveals food culture differences between Switzerland and neighbours
This content was published on
Three-quarters of Swiss people consider eating to be a pleasurable, social activity, a new survey reveals. Healthy eating, however, plays a much less important role, it found.
Addiction experts warn of shortage of methadone tablets
This content was published on
The Swiss Society of Addiction Medicine (SSAM) has warned of a possible shortage of methadone tablets in the coming weeks.
This content was published on
Switzerland is experiencing medicine shortages due to supply chain issues linked to Covid lockdowns in China and the Ukraine war.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.